Statistics
Total Visits
Views | |
---|---|
Achieving the deep molecular response levels required for an imatinib discontinuation trial is strongly associated with the BCR-ABL level at the first qualifying timepoint | 102 |
Achieving the deep molecular response levels required for an imatinib discontinuation trial is strongly associated with the BCR-ABL level at the first qualifying timepoint | 99 |
Total Visits per Month
December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
---|---|---|---|---|---|---|---|
Achieving the deep molecular response levels required for an imatinib discontinuation trial is strongly associated with the BCR-ABL level at the first qualifying timepoint | 2 | 4 | 1 | 1 | 6 | 16 | 0 |
File Downloads
Views |
---|
Top Country Views
Views | |
---|---|
United States | 55 |
China | 29 |
France | 10 |
Netherlands | 8 |
Hong Kong SAR China | 6 |
Singapore | 6 |
Australia | 5 |
Vietnam | 5 |
Argentina | 3 |
Brazil | 1 |
Top City Views
Views | |
---|---|
Ashburn | 18 |
Beijing | 10 |
Rotterdam | 8 |
Hanoi | 5 |
Singapore | 5 |
Zhengzhou | 5 |
Fairfield | 3 |
Kaleen | 3 |
Des Moines | 2 |
Qingping | 2 |